Akari Therapeutics, Plc (AKTX) Earnings
|
Expand Research on AKTX
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | 0.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -1.3% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/13/25  |
Q225 | N/A | -$0.12 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/15/25 | Q125 | $0.00 | $0.00 | $0.00 | N/A | N/A | N/A |  | | Details | |
| 12/1/23 | Q323 | N/A | -$0.60 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 9/27/23 | Q223 | N/A | -$1.00 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 6/1/23 | Q123 | N/A | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/27/23 | Q422 | N/A | $0.00 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/22/23 | Q422 | N/A | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/17/22 | Q222 | N/A | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A |
